Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatectomy | 7 | 2015 | 84 | 0.830 |
Why?
|
| Urologic Surgical Procedures | 3 | 2020 | 37 | 0.740 |
Why?
|
| Ureteral Obstruction | 2 | 2019 | 21 | 0.700 |
Why?
|
| Ureter | 2 | 2019 | 34 | 0.690 |
Why?
|
| Laparoscopy | 7 | 2014 | 467 | 0.660 |
Why?
|
| Postoperative Complications | 3 | 2019 | 1284 | 0.650 |
Why?
|
| Prostatic Neoplasms | 6 | 2015 | 399 | 0.620 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2019 | 14 | 0.620 |
Why?
|
| Pyelonephritis | 1 | 2019 | 8 | 0.620 |
Why?
|
| Kidney Transplantation | 3 | 2019 | 313 | 0.600 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2019 | 122 | 0.590 |
Why?
|
| Robotic Surgical Procedures | 2 | 2015 | 141 | 0.450 |
Why?
|
| Urinary Bladder Neoplasms | 3 | 2018 | 96 | 0.450 |
Why?
|
| Hernia, Inguinal | 2 | 2011 | 41 | 0.400 |
Why?
|
| Cystectomy | 3 | 2018 | 30 | 0.360 |
Why?
|
| Surgical Mesh | 1 | 2011 | 61 | 0.350 |
Why?
|
| Ileum | 1 | 2004 | 22 | 0.220 |
Why?
|
| Urinary Diversion | 1 | 2004 | 12 | 0.220 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2004 | 37 | 0.210 |
Why?
|
| Kidney Neoplasms | 3 | 2006 | 145 | 0.210 |
Why?
|
| Robotics | 3 | 2013 | 77 | 0.200 |
Why?
|
| Peritoneum | 3 | 2015 | 29 | 0.190 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 46 | 0.160 |
Why?
|
| Male | 19 | 2019 | 29487 | 0.160 |
Why?
|
| Cryotherapy | 1 | 1999 | 16 | 0.160 |
Why?
|
| Hypertension, Renovascular | 1 | 1999 | 6 | 0.160 |
Why?
|
| Renal Artery Obstruction | 1 | 1999 | 19 | 0.150 |
Why?
|
| Triage | 1 | 2020 | 115 | 0.150 |
Why?
|
| Renal Artery | 1 | 1999 | 34 | 0.150 |
Why?
|
| Treatment Outcome | 8 | 2019 | 5591 | 0.150 |
Why?
|
| Aged | 8 | 2019 | 14254 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 178 | 0.140 |
Why?
|
| Middle Aged | 13 | 2019 | 17365 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 203 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 217 | 0.130 |
Why?
|
| Humans | 24 | 2021 | 62682 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2019 | 562 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 255 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 1999 | 257 | 0.130 |
Why?
|
| Lymphocele | 1 | 2015 | 4 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 42 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 663 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2015 | 3258 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2014 | 55 | 0.110 |
Why?
|
| Surgical Flaps | 1 | 2015 | 117 | 0.110 |
Why?
|
| Vena Cava, Inferior | 2 | 2006 | 32 | 0.110 |
Why?
|
| Gallbladder | 1 | 2014 | 37 | 0.110 |
Why?
|
| Laparotomy | 1 | 2014 | 50 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 38 | 0.110 |
Why?
|
| Adult | 8 | 2019 | 16629 | 0.110 |
Why?
|
| Early Diagnosis | 1 | 2014 | 96 | 0.100 |
Why?
|
| Length of Stay | 2 | 2014 | 804 | 0.100 |
Why?
|
| Replantation | 1 | 2011 | 11 | 0.090 |
Why?
|
| Sutures | 1 | 2012 | 41 | 0.090 |
Why?
|
| Female | 11 | 2019 | 32495 | 0.090 |
Why?
|
| Prostate | 1 | 2012 | 81 | 0.090 |
Why?
|
| Contraindications | 1 | 2011 | 49 | 0.090 |
Why?
|
| Neoplasms | 1 | 2021 | 1350 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 660 | 0.080 |
Why?
|
| Liver | 1 | 2014 | 845 | 0.080 |
Why?
|
| Nephrectomy | 1 | 2008 | 80 | 0.070 |
Why?
|
| Administration, Intravesical | 2 | 2020 | 10 | 0.070 |
Why?
|
| Heart Arrest, Induced | 1 | 2006 | 13 | 0.070 |
Why?
|
| Living Donors | 2 | 2008 | 76 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2006 | 93 | 0.060 |
Why?
|
| Thrombectomy | 1 | 2006 | 227 | 0.060 |
Why?
|
| Thrombosis | 1 | 2006 | 199 | 0.050 |
Why?
|
| Young Adult | 1 | 2014 | 4633 | 0.050 |
Why?
|
| Mesothelioma | 1 | 2003 | 27 | 0.050 |
Why?
|
| Scrotum | 1 | 2003 | 7 | 0.050 |
Why?
|
| Peritoneal Neoplasms | 1 | 2003 | 28 | 0.050 |
Why?
|
| Genital Diseases, Male | 1 | 2003 | 8 | 0.050 |
Why?
|
| Hematoma | 1 | 2003 | 77 | 0.050 |
Why?
|
| Urethra | 2 | 2014 | 68 | 0.050 |
Why?
|
| Hypophosphatemia | 1 | 2001 | 7 | 0.050 |
Why?
|
| Vascular Neoplasms | 1 | 2001 | 17 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2001 | 63 | 0.040 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2001 | 35 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 309 | 0.040 |
Why?
|
| Urologic Diseases | 1 | 2020 | 15 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2020 | 50 | 0.040 |
Why?
|
| Office Visits | 1 | 2020 | 47 | 0.040 |
Why?
|
| Biopsy | 2 | 2013 | 430 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 104 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 1999 | 126 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 85 | 0.040 |
Why?
|
| Aneurysm | 1 | 1999 | 60 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2018 | 82 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 370 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2018 | 6533 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 839 | 0.030 |
Why?
|
| Pelvis | 1 | 2015 | 58 | 0.030 |
Why?
|
| Telemedicine | 1 | 2020 | 318 | 0.030 |
Why?
|
| United States | 2 | 2020 | 7721 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 91 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5403 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 87 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2013 | 42 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 74 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 212 | 0.030 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1992 | 2 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2012 | 2445 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 337 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 120 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2012 | 111 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2012 | 98 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2014 | 852 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1367 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 1992 | 339 | 0.020 |
Why?
|
| Ferritins | 1 | 1988 | 31 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 1988 | 81 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2008 | 120 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2008 | 89 | 0.020 |
Why?
|
| Sternum | 1 | 2006 | 29 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2006 | 56 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 2040 | 0.020 |
Why?
|
| Epirubicin | 1 | 2003 | 4 | 0.010 |
Why?
|
| Mitomycin | 1 | 2003 | 26 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2003 | 36 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1638 | 0.010 |
Why?
|
| Spermatic Cord Torsion | 1 | 2003 | 12 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 27 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 5303 | 0.010 |
Why?
|
| Cisplatin | 1 | 2003 | 139 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2001 | 28 | 0.010 |
Why?
|
| Subclavian Artery | 1 | 2001 | 26 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 933 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2001 | 43 | 0.010 |
Why?
|
| Heart Atria | 1 | 2001 | 138 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 964 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 445 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2003 | 1341 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 3742 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 1992 | 101 | 0.010 |
Why?
|
| Hyperthyroidism | 1 | 1988 | 18 | 0.000 |
Why?
|
| Hypothyroidism | 1 | 1988 | 42 | 0.000 |
Why?
|
| Child | 1 | 1988 | 4444 | 0.000 |
Why?
|
| Adolescent | 1 | 1988 | 6172 | 0.000 |
Why?
|